Prenetics Global Ltd. (PRE)
21.84
-0.16
(-0.73%)
USD |
NASDAQ |
Oct 09, 16:00
21.76
-0.08
(-0.37%)
After-Hours: 20:00
Prenetics Global Enterprise Value : 256.60M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 256.60M |
| October 08, 2026 | 259.28M |
| October 07, 2026 | 267.15M |
| October 06, 2026 | 232.51M |
| October 05, 2026 | 241.88M |
| October 02, 2026 | 228.66M |
| October 01, 2026 | 258.45M |
| September 30, 2026 | 278.19M |
| September 29, 2026 | 273.34M |
| September 28, 2026 | 272.00M |
| September 25, 2026 | 275.51M |
| September 24, 2026 | 274.84M |
| September 23, 2026 | 271.16M |
| September 22, 2026 | 274.34M |
| September 21, 2026 | 298.43M |
| September 18, 2026 | 295.92M |
| September 17, 2026 | 295.92M |
| September 16, 2026 | 259.62M |
| September 15, 2026 | 277.35M |
| September 14, 2026 | 294.75M |
| September 11, 2026 | 283.88M |
| September 10, 2026 | 287.06M |
| September 09, 2026 | 297.26M |
| September 08, 2026 | 319.85M |
| September 04, 2026 | 316.84M |
| Date | Value |
|---|---|
| September 03, 2026 | 320.02M |
| September 02, 2026 | 327.04M |
| September 01, 2026 | 323.03M |
| August 31, 2026 | 330.39M |
| August 28, 2026 | 322.19M |
| August 27, 2026 | 330.39M |
| August 26, 2026 | 322.53M |
| August 25, 2026 | 280.20M |
| August 24, 2026 | 256.27M |
| August 21, 2026 | 229.17M |
| August 20, 2026 | 191.86M |
| August 19, 2026 | 205.07M |
| August 18, 2026 | 215.78M |
| August 17, 2026 | 215.28M |
| August 14, 2026 | 221.64M |
| August 13, 2026 | 220.80M |
| August 12, 2026 | 203.74M |
| August 11, 2026 | 209.26M |
| August 10, 2026 | 205.74M |
| August 07, 2026 | 196.71M |
| August 06, 2026 | 190.02M |
| August 05, 2026 | 200.05M |
| August 04, 2026 | 201.89M |
| August 03, 2026 | 201.06M |
| July 31, 2026 | 203.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Global Cord Blood Corp. | -- |
| Exlites Holdings International, Inc. | 19.82M |
| Xcelerate, Inc. | 10.42M |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Fresenius SE & Co. KGaA | 39.38B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.088M |
| Revenue (Quarterly) | 46.49M |
| Total Expenses (Quarterly) | 55.58M |
| EPS Diluted (Quarterly) | -0.5203 |
| Gross Profit Margin (Quarterly) | 64.97% |
| Profit Margin (Quarterly) | -19.55% |
| Earnings Yield | -19.08% |
| Normalized Earnings Yield | -14.25 |